OSP News

Blue Cross Complete Announces COVID-19 Administration of Vaccine and Booster – Coding Update

Posted: 01/05/2022

The U.S. Food and Drug Administration (US FDA) expanded use of the COVID-19 booster and recently authorized the Pfizer-BioNTech vaccine for moderately or severely immunocompromised children 5 through 11 years of age. Click here, for coding information on administration of the COVID-19 vaccines and boosters.

We value your privacy. We use cookies and other technologies to keep the web site reliable and secure, tailor your experience, and measure web site performance, as described in our Privacy Policy.

x

OSP Technical Support